USAID Health: HIV/AIDS, Overview

USAID: From The American People - Link to USAID Home Page

Over 3 million children receive vitamin A supplements through USAID program in Nepal - Click to read this story

Overview »
Environmental Health »
Health Systems »
HIV/AIDS »
Infectious Diseases »
Maternal & Child Health »
Nutrition »
Family Planning »
American Schools and Hospitals Abroad »

RSS Feed for Recent HIV/AIDS WebSource Articles

Get Acrobat Reader...

Subscribe to receive free
e-newsletters and updates from USAID on global health.

Social Media at USAID

∙

∙

∙

Contact Global Health

Welcome

Since the inception of its HIV/AIDS program in 1986, the U.S. Agency for International Development (USAID) has been on the forefront of the global AIDS crisis, investing more than $7 billion to fight the pandemic. Today, with more than 33 million people living with or affected by HIV/AIDS, USAID is a key partner in the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the largest and most diverse HIV/AIDS prevention, care, and treatment initiative in the world.

   Global AIDS 101 – Learn the basics about HIV/AIDS.
   Download the HIV/AIDS Fast Facts to learn more [PDF, 131KB].
   Learn more about the HIV/AIDS technical areas.

	USAID HIV/AIDS Programs
Cick on a region and learn more about our HIV/AIDS programs.

	HIV/AIDS Worldwide News
7/28/10: Washington, D.C. - International Partnership Awarded for Excellence in Supply Chain for HIV/AIDS Commodities 7/20/10: Austria - Study of Microbicide Gel Shows Reduced Risk of HIV & Herpes Infections in Women 7/19/10: Washington, D.C. - Statement from USAID Administrator Rajiv Shah in Response to Today's Historic Progress in Preventing HIV Infection in Women 6/18/10: Washington, D.C. - U.S. Government Support for Global Health Efforts

Features

Stay Informed with Global Health E-News
USAID is happy to offer a free e-mail subscription to its bimonthly Global Health e-newsletter, along with periodic e-mail updates on special events. The e-newsletter provides subscribers with the latest news, developments, events, speeches, and resources on global health from USAID.

Subscribe to Global Health E-News now.

View the most recent edition of Global Health E-News.

CAPRISA Trial Provides Evidence That Microbicide Can Prevent HIV Infection
The Center for the AIDS Program of Research in South Africa (CAPRISA) 004 trial recently completed in Durban, South Africa. Results from the trial provided the first ever proof of concept that a vaginal microbicide could safely and effectively reduce the risk of heterosexual transmission of HIV from men to vulnerable women. The use of 1% tenofovir gel by 889 women at high risk of HIV infection proved the method to be 39 percent effective in reducing a woman�s risk of becoming HIV infected.

Once these results are confirmed in further studies, this microbicide could be a unique HIV prevention tool for women who are not able to negotiate HIV prevention methods. USAID will continue to work with PEPFAR, multi-lateral agencies, and partner countries to ensure the full impact of this advance can be offered to vulnerable women and girls world-wide and especially in low-resource settings. USAID funded 90 percent of the $18 million budget for this trial, which was conducted by CAPRISA with assistance from two USAID-funded implementing partners, FHI and CONRAD.

Read Administrator Shah�s statement

Read the full press release

Read about USAID�s microbicide program

About USAID

Our Work

Locations

Public Affairs

Careers

Business/Policy

: : : : : : : : : :		What's New : FOIA Requests : Privacy Policy : Email This Page : Plug-ins : FAQs : Help Desk : Contact Us : Site Map Thu, 29 Jul 2010 15:12:36 -0500
Last Updated on: July 29, 2010